Show simple item record

dc.contributor.authorMurray, J
dc.contributor.authorTree, AC
dc.date.accessioned2021-02-22T12:11:25Z
dc.date.available2021-02-22T12:11:25Z
dc.identifier.citationClinical and translational radiation oncology, 2019, 18 pp. 68 - 73en_US
dc.identifier.issn2405-6308
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4356
dc.identifier.eissn2405-6308en_US
dc.identifier.eissn2405-6308
dc.identifier.doi10.1016/j.ctro.2019.03.006en_US
dc.identifier.doi10.1016/j.ctro.2019.03.006
dc.description.abstractExternal beam radiotherapy for prostate cancer is an optimal treatment choice for men with localised prostate cancer and is associated with long term disease control in most patients. Image-guided prostate radiotherapy is standard of care, however, current techniques can include invasive procedures with imaging of poor soft tissue resolution, thus limiting accuracy. MRI is the imaging of choice for local prostate cancer staging and in radiotherapy planning has been shown to reduce target volume and reduce inter-observer prostate contouring variability. The ultimate aim would be to have a MR-only workflow for prostate radiotherapy. Within this article, we discuss these opportunities and challenges, relevant due to the increasing availability of MR-guided radiotherapy. Prospective multi-centre studies are underway to determine the feasibility of MR-guided prostate radiotherapy and daily adaptive replanning. In parallel, development and adaptation of the existing radiotherapy multidisciplinary workforce is essential to enable an efficient and effective MR-guided radiotherapy workflow. This technology potentially provides us with the anatomical and biological information to further improve outcomes for our patients.en_US
dc.formatElectronic-eCollectionen_US
dc.format.extent68 - 73en_US
dc.languageengen_US
dc.language.isoengen_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.titleProstate cancer - Advantages and disadvantages of MR-guided RT.en_US
dc.typeJournal Article
dcterms.dateAccepted2019-03-30
rioxxterms.versionVoRen_US
rioxxterms.versionofrecord10.1016/j.ctro.2019.03.006en_US
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by-nc-nd/4.0en_US
dc.relation.isPartOfClinical and translational radiation oncologyen_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams/Clinical Academic Radiotherapy (Dearnaley)
pubs.publication-statusPublisheden_US
pubs.volume18en_US
pubs.embargo.termsNot knownen_US
icr.researchteamClinical Academic Radiotherapy (Dearnaley)
dc.contributor.icrauthorTree, Alisonen_US
dc.contributor.icrauthorMurray, Juliaen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/